Literature DB >> 29167623

Bioresorbable Vascular Scaffold Stent Delivered to Tortuous Lesions by Using the "Five-in-Six" System.

Wen-Jung Chung1,2, Hsiu-Yu Fang1,2, Chiung-Jen Wu1,2.   

Abstract

A 5Fr ST01, which is a straight-tip guiding catheter with an inner lumen of 1.5 mm, is frequently used to perform the "child-in-mother" technique, which is also referred to as the "5-in-6" technique. A 6Fr or larger size guiding catheter can facilitate bioresorbable everolimus-eluting vascular scaffold (BVS) delivery. For tortuous lesions, the 5-in-6 technique can facilitate balloon catheters and the BVS in crossing tortuous lesions by increasing the back-up support. However, this maneuver couldn't be used for the larger size of BVS like 3.5-mm. Besides, it is necessary to preload the BVS into 5Fr ST01 guiding catheter to check whether this could really be done. We present a case in which a 5Fr ST01 catheter and the 5-in-6 technique were successfully used in distal delivery of a BVS to cross a very tortuous right coronary artery lesion.

Entities:  

Keywords:  Child-in-mother system; Coronary intervention; Transradial

Year:  2017        PMID: 29167623      PMCID: PMC5694934          DOI: 10.6515/ACS20170413A

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  8 in total

1.  The crooked buddy technique: use of a Wiggle wire alongside an extra support wire to improve device deliverability.

Authors:  B Scott Chism; Richard W Lee; John P Sweeney; F David Fortuin
Journal:  J Invasive Cardiol       Date:  2010-08       Impact factor: 2.022

2.  New method to increase a backup support of a 6 French guiding coronary catheter.

Authors:  Saeko Takahashi; Shigeru Saito; Shinji Tanaka; Yusuke Miyashita; Takaaki Shiono; Fumio Arai; Hiroshi Domae; Shutaro Satake; Takenari Itoh
Journal:  Catheter Cardiovasc Interv       Date:  2004-12       Impact factor: 2.692

3.  Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization?

Authors:  Yosinobu Onuma; Patrick W Serruys
Journal:  Circulation       Date:  2011-02-22       Impact factor: 29.690

4.  Transradial complex coronary interventions using a five-in-six system.

Authors:  Kentaro Hayashida; Yves Louvard; Thierry Lefèvre
Journal:  Catheter Cardiovasc Interv       Date:  2011-01-01       Impact factor: 2.692

5.  Mechanism and predictors of failed transradial approach for percutaneous coronary interventions.

Authors:  Payam Dehghani; Atif Mohammad; Ravi Bajaj; Tony Hong; Colin M Suen; Waseem Sharieff; Robert J Chisholm; Michael J B Kutryk; Neil P Fam; Asim N Cheema
Journal:  JACC Cardiovasc Interv       Date:  2009-11       Impact factor: 11.195

6.  Use of 'Guideliner' catheter to overcome failure of delivery of Absorb™ Bioresorbable Vascular Scaffold in calcified tortuous coronary lesions: technical considerations in 'Real World Patients'.

Authors:  Ashok Seth; Vinayak Ravisekar; U Kaul
Journal:  Indian Heart J       Date:  2014 Jul-Aug

7.  [The use of the Five-in-Six System for stent delivery in challenging coronary lesions: a multi-center experience].

Authors:  Y Derraz; H Benamer; T Lefèvre; B Chevalier; T Hovasse; R Chaito; P Garot; M-C Morice; Y Louvard
Journal:  Ann Cardiol Angeiol (Paris)       Date:  2013-10-08

8.  Biodegradable vascular scaffold ABSORB BVS™ - scientific evidence and methods of implantation.

Authors:  Lukasz Rzeszutko; Rafał Depukat; Dariusz Dudek
Journal:  Postepy Kardiol Interwencyjnej       Date:  2013-03-21       Impact factor: 1.426

  8 in total
  1 in total

1.  Left ventricular structure and function in patients with chronic kidney disease assessed by 3D echocardiography: the CPH-CKD ECHO study.

Authors:  Jacob Christensen; Nino Emanuel Landler; Flemming Javier Olsen; Bo Feldt-Rasmussen; Ditte Hansen; Anne-Lise Kamper; Christina Christoffersen; Ellen Linnea Freese Ballegaard; Ida Maria Hjelm Sørensen; Sasha Saurbrey Bjergfelt; Eline Seidelin; Susanne Bro; Tor Biering-Sørensen
Journal:  Int J Cardiovasc Imaging       Date:  2021-12-31       Impact factor: 2.357

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.